Optimize your biosimilar development strategy

Duration: 43 minutes

Webinar Recording

First Name (Required)

Last Name (Required)

Business Email (Required)

Company (Required)

Job Title (Required)

Phone Number

Where are you located? (Required)

State (Required)

GDPR Please tick this box to consent to our privacy policy.

Opt-In Please tick this box if you agree to receive periodic updates from PharmaLex. You can unsubscribe at any time at data.protection@pharmalex.com.

Comments

If you do not wish to receive any communication from us, you may unsubscribe at any time. Click here to view our privacy policy.

Why watch

Key Learnings

Define Commercial Strategy
Product Characterization
CMC Development & Similarity
Non-Clinical & Clinical Approach

speakers

A full day of inspirational speakers

Proud to bring inspirational speakers from across the globe.

Zeb Younes

Director, Regulatory Affairs, PharmaLex

Zeb Younes has over 16 years of experience in biopharmaceutical / biosimilar development lifecycle from proof of concept through to, and beyond commercialization with both laboratory and desk based experience in process development, purification, formulation, method development, characterisation, validation, comparability, release and stability testing. Zeb has experience with ATMPs, vaccines, recombinant proteins including monoclonal antibodies and derivatives and over 10 different biosimilar products.